Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery disease

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 311, Issue 2, 2016, Pages R392-R400

  Neff, Dustin ^a   Kuhlenhoelter, Alisha M ^a   Lin, Chen ^b   Wong, Brett J ^c   Motaganahalli, Raghu L ^b   Roseguini, Bruno T ^a  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Blood flow; Intermittent claudication; Thermotherapy

Indexed keywords

ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ALPHA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NOX PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; AUTACOID;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DIASTOLIC BLOOD PRESSURE; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; INTERMITTENT CLAUDICATION; LEG BLOOD FLOW; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; SIX MINUTE WALK TEST; SKIN TEMPERATURE; SYSTOLIC BLOOD PRESSURE; THERMOTHERAPY; BLOOD; COMPLICATION; HYPERTENSION; LEG; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASCULARIZATION;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; HYPERTHERMIA, INDUCED; INFLAMMATION MEDIATORS; LEG; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; TREATMENT OUTCOME;

EID: 84984633166     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00147.2016     Document Type: Article

References (63)

1. Barbosa JP, Farah BQ, Chehuen M, Cucato GG, Farias Junior JC, Wolosker N, Forjaz CL, Gardner AW, Ritti-Dias RM. Barriers to physical activity in patients with intermittent claudication. Int J Behav Med 22: 70-76, 2015.
2. Bartelink ML, Stoffers HE, Biesheuvel CJ, Hoes AW. Walking exercise in patients with intermittent claudication. Experience in routine clinical practice. Br J Gen Pract 54: 196-200, 2004.
3. Bohm F, Ahlborg G, Johansson BL, Hansson LO, Pernow J. Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis. Arterioscler Thromb Vasc Biol 22: 674-679, 2002.
4. Bohm F, Beltran E, Pernow J. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition. J Int Med 257: 263-271, 2005.
5. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76: 8-18, 2007.
6. Bonaca MP, Creager MA. Pharmacological treatment and current management of peripheral artery disease. Circ Res 116: 1579-1598, 2015.
7. Bouchama A, Ollivier V, Roberts G, Al Mohanna F, de Prost D, Eldali A, Saussereau E, El-Sayed R, Chollet-Martin S. Experimental heatstroke in baboon: analysis of the systemic inflammatory response. Shock 24: 332-335, 2005.
8. Bouchama A, Roberts G, Al Mohanna F, El-Sayed R, Lach B, Chollet-Martin S, Ollivier V, Al Baradei R, Loualich A, Nakeeb S, Eldali A, de Prost D. Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke. J Appl Physiol 98: 697-705, 2005.
9. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation 122: 1862-1875, 2010.
10. Cardillo C, Kilcoyne CM, Cannon RO, 3rd, Panza JA. Increased activity of endogenous endothelin in patients with hypercholesterolemia. J Am Coll Cardiol 36: 1483-1488, 2000.
11. Chiesa ST, Trangmar SJ, Gonzalez-Alonso J. Temperature and blood flow distribution in the human leg during passive heat stress. J Appl Physiol 120: 1047-1058, 2016.
12. Chiesa ST, Trangmar SJ, Kalsi KK, Rakobowchuk M, Banker DS, Lotlikar MD, Ali L, Gonzalez-Alonso J. Local temperature-sensitive mechanisms are important mediators of limb tissue hyperemia in the heat-stressed human at rest and during small muscle mass exercise. Am J Physiol Heart Circ Physiol 309: H369-H380, 2015.
13. Clement DL, De Buyzere ML, Duprez DA. Hypertension in peripheral arterial disease. Curr Pharmaceut Design 10: 3615-3620, 2004.
14. Crandall CG, Wilson TE. Human cardiovascular responses to passive heat stress. Compr Physiol 5: 17-43, 2015.
15. Cucato GG, Chehuen Mda R, Ritti-Dias RM, Carvalho CR, Wolosker N, Saxton JM, Forjaz CL. Post-walking exercise hypotension in patients with intermittent claudication. Med Sci Sports Exerc 47: 460-467, 2015.
16. De Haro J, Bleda S, Varela C, Esparza L, Acin F, Bosentan Population-Based Randomized Trial for C., and Endothelial Function Assessment on Endothelin Antagonist Therapy in Patients With Intermittent Claudication I. Effect of Bosentan on claudication distance and endothelium-dependent vasodilation in hispanic patients with peripheral arterial disease. Am J Cardiol 117: 295-301, 2016.
17. de Haro Miralles J, Gonzalez AF, Varela Casariego C, Garcia FA. Onset of peripheral arterial disease: role of endothelin in endothelial dysfunction. Interact Cardiovasc Thorac Surg 10: 760-765, 2010.
18. de Liefde II, Hoeks SE, van Gestel YR, Bax JJ, Klein J, van Domburg RT, Poldermans D. Usefulness of hypertensive blood pressure response during a single-stage exercise test to predict long-term outcome in patients with peripheral arterial disease. Am J Cardiol 102: 921-926, 2008.
19. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382: 1329-1340, 2013.
20. Gagnon D, Schlader ZJ, Crandall CG. Sympathetic activity during passive heat stress in healthy aged humans. J Physiol 593: 2225-2235, 2015.
21. Galea MN, Bray SR, Ginis KA. Barriers and facilitators for walking in individuals with intermittent claudication. J Aging Phys Act 16: 69-83; quiz 84, 2008.
22. Ganio MS, Brothers RM, Shibata S, Hastings JL, Crandall CG. Effect of passive heat stress on arterial stiffness. Exp Physiol 96: 919-926, 2011.
23. Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc 3: e001107, 2014.
24. Green DJ, Carter HH, Fitzsimons MG, Cable NT, Thijssen DH, Naylor LH. Obligatory role of hyperaemia and shear stress in microvascular adaptation to repeated heating in humans. J Physiol 588: 1571-1577, 2010.
25. Grozinger G, Pohmann R, Schick F, Grosse U, Syha R, Brechtel K, Rittig K, Martirosian P. Perfusion measurements of the calf in patients with peripheral arterial occlusive disease before and after percutaneous transluminal angioplasty using MR arterial spin labeling. J Magn Reson Imaging 40: 980-987, 2014.
26. Hecksteden A, Grutters T, Meyer T. Association between postexercise hypotension and long-term training-induced blood pressure reduction: a pilot study. Clin J Sport Med 23: 58-63, 2013.
27. Heinonen I, Brothers RM, Kemppainen J, Knuuti J, Kalliokoski KK, Crandall CG. Local heating, but not indirect whole body heating, increases human skeletal muscle blood flow. J Appl Physiol 111: 818-824, 2011.
28. Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, Otsuji Y, Minagoe S, Toyama Y, Tei C. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 38: 1083-1088, 2001.
29. Johnson JM, Minson CT, Kellogg DL Jr. Cutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation. Compr Physiol 4: 33-89, 2014.
30. Kalsi KK, Gonzalez-Alonso J. Temperature-dependent release of ATP from human erythrocytes: mechanism for the control of local tissue perfusion. Exp Physiol 97: 419-432, 2012.
31. Keller DM, Sander M, Stallknecht B, Crandall CG.-Adrenergic vasoconstrictor responsiveness is preserved in the heated human leg. J Physiol 588: 3799-3808, 2010.
32. Kihara T, Biro S, Imamura M, Yoshifuku S, Takasaki K, Ikeda Y, Otuji Y, Minagoe S, Toyama Y, Tei C. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol 39: 754-759, 2002.
33. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117, 2002.
34. Lane DA, Lip GY. Treatment of hypertension in peripheral arterial disease. Cochrane Database Syst Rev 12: CD003075, 2013.
35. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325: 997-1001, 1991.
36. Leslie SJ, Rahman MQ, Denvir MA, Newby DE, Webb DJ. Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. Br J Clin Pharmacol 57: 720-725, 2004.
37. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS, American Heart Association Committee on Diagnostic and Interventional Cardiac C., American Heart Association Council on Clinical Catheterization, American Heart Association Council on Cardiovascular Radiology, and Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 116: 2878-2891, 2007.
38. Liao JK, Bettmann MA, Sandor T, Tucker JI, Coleman SM, Creager MA. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res 68: 1027-1034, 1991.
39. Liu S, Goodman J, Nolan R, Lacombe S, Thomas SG. Blood pressure responses to acute and chronic exercise are related in prehypertension. Med Sci Sports Exerc 44: 1644-1652, 2012.
40. Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attina T, Dell’Arte S, Sarnataro F. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication. Int J Clin Pharmacol Ther 37: 347-351, 1999.
41. Mangiafico RA, Malatino LS, Santonocito M, Sarnataro F, Dell’Arte S, Messina R, Santangelo B. Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine’s stages. Panminerva Med 41: 22-26, 1999.
42. Masuda A, Miyata M, Kihara T, Minagoe S, Tei C. Repeated sauna therapy reduces urinary 8-epi-prostaglandin F(2). Jpn Heart J 45: 297-303, 2004.
43. McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res 116: 1540-1550, 2015.
44. McDermott MM, Guralnik JM, Criqui MH, Liu K, Kibbe MR, Ferrucci L. Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation 130: 61-68, 2014.
45. McDermott MM, Hoff F, Ferrucci L, Pearce WH, Guralnik JM, Tian L, Liu K, Schneider JR, Sharma L, Tan J, Criqui MH. Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc 55: 400-406, 2007.
46. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, Pearce WH, Schneider JR, Ferrucci L, Celic L, Taylor LM, Vonesh E, Martin GJ, Clark E. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 292: 453-461, 2004.
47. McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, Tao H, Zhao L, Liao Y, Rejeski WJ. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA 310: 57-65, 2013.
48. Muller MD, Reed AB, Leuenberger UA, Sinoway LI. Physiology in medicine: peripheral arterial disease. J Appl Physiol 115: 1219-1226, 2013.
49. Naylor LH, Carter H, FitzSimons MG, Cable NT, Thijssen DH, Green DJ. Repeated increases in blood flow, independent of exercise, enhance conduit artery vasodilator function in humans. Am J Physiol Heart Circ Physiol 300: H664-H669, 2011.
50. Newton DJ, Khan F, McLaren M, Kennedy G, Belch JJ. Endothelin-1 levels predict 3-year survival in patients who have amputation for critical leg ischaemia. Br J Surg 92: 1377-1381, 2005.
51. Nohria A, Garrett L, Johnson W, Kinlay S, Ganz P, Creager MA. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Hypertension 42: 43-48, 2003.
52. Ohori T, Nozawa T, Ihori H, Shida T, Sobajima M, Matsuki A, Yasumura S, Inoue H. Effect of repeated sauna treatment on exercise tolerance and endothelial function in patients with chronic heart failure. Am J Cardiol 109: 100-104, 2012.
53. Pearson J, Low DA, Stohr E, Kalsi K, Ali L, Barker H, Gonzalez-Alonso J. Hemodynamic responses to heat stress in the resting and exercising human leg: insight into the effect of temperature on skeletal muscle blood flow. Am J Physiol Regul Integr Comp Physiol 300: R663-R673, 2011.
54. Pernow J, Shemyakin A, Bohm F. New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sci 91: 507-516, 2012.
55. Regensteiner JG. Exercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment. Curr Drug Targets Cardiovasc Haematol Disord 4: 233-239, 2004.
56. Roseguini BT, Hirai DM, Alencar MC, Ramos RP, Silva BM, Wolosker N, Neder JA, Nery LE. Sildenafil improves skeletal muscle oxygenation during exercise in men with intermittent claudication. Am J Physiol Regul Integr Comp Physiol 307: R396-R404, 2014.
57. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study Circulation 82: 1925-1931, 1990.
58. Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 134: 648-654, 2001.
59. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 347: 1941-1951, 2002.
60. Thorin E, Webb DJ. Endothelium-derived endothelin-1. Pflügers Arch 459: 951-958, 2010.
61. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97: 752-756, 1998.
62. Welc SS, Clanton TL, Dineen SM, Leon LR. Heat stroke activates a stress-induced cytokine response in skeletal muscle. J Appl Physiol 115: 1126-1137, 2013.
63. Wilkinson DM, Carter JM, Richmond VL, Blacker SD, Rayson MP. The effect of cool water ingestion on gastrointestinal pill temperature. Med Sci Sports Exerc 40: 523-528, 2008.